RN7SL825P

Across TCGA pan-cancer cohorts, RN7SL825P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RN7SL825P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RN7SL825P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL825P expression acts as an unfavorable survival marker, although some lineages such as COAD and SKCM show a favorable association.

KIRC, ACC, and LIHC are the cancer types where RN7SL825P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.545	0.702	<.001	165	view →
ACC	OS	Median	All	0.369	0.852	<.001	108	view →
LIHC	DFS	Quartile	II,III,IV	0.219	0.530	<.001	70	view →
KICH	DFS	Tertile	II,III,IV	0.500	1.000	.001	69	view →
CESC	OS	Quartile	All	0.789	0.890	.003	44	view →
DLBC	DFS	Median	III,IV	0.140	0.917	.010	33	view →
BRCA	OS	Tertile	IV	0.280	0.705	.003	28	view →
COAD	OS	Tertile	III,IV	0.905	0.730	.005	26	view →
SKCM	OS	Median	All	0.402	0.246	.002	18	view →
LUAD	DFS	Quartile	III,IV	0.222	0.466	.011	15	view →
LUSC	DFS	Median	All	0.707	0.589	.007	13	view →
UVM	DFS	Tertile	III,IV	0.146	0.670	.020	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RN7SL825P–KIRC (OS)

Open the KIRC breakdown →